Soroka University Medical Center
Beersheba, Israel
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 2
A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.
Multiple Myeloma, Refractory
Karyopharm Therapeutics Inc127 enrolled16 locationsNCT04414475
Recruiting
Phase 3
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Janssen Research & Development, LLC120 enrolled79 locationsNCT05923073
Recruiting
Not Applicable
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Rectal CancerRectal TumorRectal/Anal
Colospan Ltd.250 enrolled14 locationsNCT04184973
Recruiting
Not Applicable
Accelerated Rotational Field Deep TMS for Treating OCD
Obsessive-Compulsive Disorder
Ben-Gurion University of the Negev50 enrolled1 locationNCT07116785
Recruiting
Phase 3
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Acute Lymphoblastic Leukemia, Pediatric
Martin Schrappe5,000 enrolled115 locationsNCT03643276
Recruiting
Phase 2
Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Crohn's Disease RelapseBiological Substance; Adverse Effect
Rambam Health Care Campus180 enrolled9 locationsNCT05599347
Recruiting
Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
Lymph Node MetastasesDifferentiated Thyroid Cancer
Soroka University Medical Center250 enrolled5 locationsNCT05078853
Recruiting
Not Applicable
A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
Crohn Disease
Soroka University Medical Center200 enrolled4 locationsNCT06221254